Jean-Paul Renaud

Questioner
DISC Type : c

Associate at Time for the Planet

Greater Strasbourg Metropolitan Area, France

Overview

Jean-Paul Renaud is a co-founder, President, and CSO at Urania Therapeutics, where he applies his Ph. D. in developing drugs for genetic diseases. A respected scientist and entrepreneur, he also co-founded NovAliX and chairs its "Biophysics in Drug Discovery" conference. Colleagues describe him as a brilliant, honest, and clever business partner.

Beyond his extensive scientific work, Jean-Paul demonstrates an appreciation for fine art. He has shared paintings from the Impressionist era, such as works by John Singer Sargent, indicating a potential personal interest in late 19th-century European and American art.

Unique fact: He successfully transitioned from a career in French public research labs to co-founding two separate biopharmaceutical companies.

Personality Overview

Not Easily Convinced

Price-Sensitive

Value Seeker

They generally do not appreciate an overfriendly approach and prefer to stay to-the-point.  While they don't hesitate to ask questions, they are generally risk-averse and tend to be late adopters. They are more likely than others to negotiate on pricing and terms.

Topics They Care About

Biophysics in Drug Discovery
He is the Chairman and Scientific Organizer for the NovAliX conference series dedicated to this subject, which he actively promotes.
Ribosome-Targeted Therapeutics
His current company, Urania Therapeutics, is founded on developing novel compounds targeting the human ribosome to treat genetic diseases caused by nonsense mutations.
Future of European Pharma
He follows the strategic direction of the pharmaceutical sector in Europe, sharing insights from major industry leaders like the CEO of AstraZeneca.

Media Appearances

Jean-Paul has no verified media appearances

Work History

12-2020
Associate at Time for the Planet
1-2017 - 12-2021
Member of the Board at French Biophysical Society
10-2015
President & CSO, Co-Founder at Urania Therapeutics
1-2015 - 12-2018
Member of the CNRS National Committee (CSI INC, 2015-2018) at CNRS
2013
Initiator, Chairman & Scientific Organizer of the NovAliX Conferences "Biophysics in Drug Discovery" at NovAliX

Education

1982 - 1985
PhD / Doctorat (1986) from Université Pierre et Marie Curie (Paris 6)
1981 - 1982
Masters / Diplôme d'Etudes Approfondies (1982) from Université Pierre et Marie Curie (Paris 6)

More Information

Social Presence :

Prographics :

Exp : 38 Location : Greater Strasbourg Metropolitan Area, France Job Level : Leadership Designation : Associate at Time for the Planet
URL has been copied!

Insights For Selling To Jean-Paul

During A Call Or A Meeting

DO's

  • Emphasize on objective proof of ROI, help them do a thorough evaluation
  • Tell them that you will come back if you don’t have a good answer for a question
  • Back up any claims with data and numbers

DONT's

  • Avoid phrases like ‘do not worry about’, ‘no one compares to’ etc.
  • Don’t try to be too friendly or informal with them
  • Don’t depend too much on anecdotal evidence, it reduces their confidence

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Jean-Paul is

  • Confidence that the product provides ROI, effective pricing and process adherence matter the most to them.

  • Will you ever get a clear answer from Jean-Paul

  • It doesn’t come naturally to them but they can say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Jean-Paul move?

  • They can move at a reasonable pace while making their decisions if they have the necessary information.

  • Can Jean-Paul take some risk or not?

  • They can take some risk if they are confident that they have analyzed the circumstances well.


You And Jean-Paul

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.